ALT
Price
$7.07
Change
-$0.08 (-1.12%)
Updated
Jun 13, 02:34 PM (EDT)
Capitalization
579.91M
55 days until earnings call
NRXS
Price
$2.26
Change
-$0.04 (-1.74%)
Updated
Jun 13, 03:11 PM (EDT)
Capitalization
21.91M
Interact to see
Advertisement

ALT vs NRXS

Header iconALT vs NRXS Comparison
Open Charts ALT vs NRXSBanner chart's image
Altimmune
Price$7.07
Change-$0.08 (-1.12%)
Volume$2.7K
Capitalization579.91M
Neuraxis
Price$2.26
Change-$0.04 (-1.74%)
Volume$1.41K
Capitalization21.91M
ALT vs NRXS Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. NRXS commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongBuy and NRXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (ALT: $7.15 vs. NRXS: $2.30)
Brand notoriety: ALT and NRXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 258% vs. NRXS: 5%
Market capitalization -- ALT: $579.91M vs. NRXS: $21.91M
ALT [@Biotechnology] is valued at $579.91M. NRXS’s [@Biotechnology] market capitalization is $21.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $352B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileNRXS’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • NRXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALT and NRXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while NRXS’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 4 bearish.
  • NRXS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALT is a better buy in the short-term than NRXS.

Price Growth

ALT (@Biotechnology) experienced а +30.95% price change this week, while NRXS (@Biotechnology) price change was -11.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.78%. For the same industry, the average monthly price growth was +21.12%, and the average quarterly price growth was +7.56%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($580M) has a higher market cap than NRXS($21.9M). ALT YTD gains are higher at: -0.832 vs. NRXS (-2.128). NRXS has higher annual earnings (EBITDA): -8.11M vs. ALT (-90.75M). ALT has more cash in the bank: 150M vs. NRXS (2.01M). NRXS has less debt than ALT: NRXS (389K) vs ALT (1.59M). NRXS has higher revenues than ALT: NRXS (2.94M) vs ALT (20K).
ALTNRXSALT / NRXS
Capitalization580M21.9M2,648%
EBITDA-90.75M-8.11M1,119%
Gain YTD-0.832-2.12839%
P/E RatioN/AN/A-
Revenue20K2.94M1%
Total Cash150M2.01M7,481%
Total Debt1.59M389K408%
FUNDAMENTALS RATINGS
ALT: Fundamental Ratings
ALT
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALTNRXS
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 25 days ago
81%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPH31.250.15
+0.48%
Tri Pointe Homes
VIVK0.86N/A
+0.26%
Vivakor
CRGX4.48-0.01
-0.22%
CARGO Therapeutics
TROW94.58-0.52
-0.55%
T Rowe Price Group
OPK1.34-0.01
-0.74%
OPKO Health

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+9.33%
CRNX - ALT
50%
Loosely correlated
-0.49%
COGT - ALT
47%
Loosely correlated
-0.55%
VKTX - ALT
47%
Loosely correlated
-1.28%
XNCR - ALT
46%
Loosely correlated
-0.95%
DNLI - ALT
45%
Loosely correlated
-1.74%
More

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
-7.63%
CVM - NRXS
59%
Loosely correlated
-4.44%
BTAI - NRXS
27%
Poorly correlated
-1.12%
CTMX - NRXS
25%
Poorly correlated
+6.03%
ALT - NRXS
24%
Poorly correlated
+9.33%
MRVI - NRXS
24%
Poorly correlated
-0.88%
More